Genetic Modification of T Cells
AbstractGene transfer technology and its application to human gene therapy greatly expanded in the last decade. One area of investigation that appears particularly promising is the transfer of new genetic material into T cells for the potential treatment of cancer. Herein, we describe several core technologies that now yield high-efficiency gene transfer into primary human T cells. These gene transfer techniques include viral-based gene transfer methods based on modified Retroviridae and non-viral methods such as DNA-based transposons and direct transfer of mRNA by electroporation. Where specific examples are cited, we emphasize the transfer of chimeric antigen receptors (CARs) to T cells, which permits engineered T cells to recognize potential tumor antigens. View Full-Text
Share & Cite This Article
Morgan, R.A.; Boyerinas, B. Genetic Modification of T Cells. Biomedicines 2016, 4, 9.
Morgan RA, Boyerinas B. Genetic Modification of T Cells. Biomedicines. 2016; 4(2):9.Chicago/Turabian Style
Morgan, Richard A.; Boyerinas, Benjamin. 2016. "Genetic Modification of T Cells." Biomedicines 4, no. 2: 9.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.